BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8100171)

  • 1. Tyr-MIF-1 precipitates abstinence syndrome in morphine-dependent rats.
    Malin DR; Zadina JE; Lake JR; Rogillio RB; Leyva JE; Benson TM; Corriere LS; Handunge BP; Kastin AJ
    Brain Res; 1993 Apr; 610(1):169-71. PubMed ID: 8100171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
    Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
    Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome.
    Malin DH; Lake JR; Arcangeli KR; Deshotel KD; Hausam DD; Witherspoon WE; Carter VA; Yang HY; Pal B; Burgess K
    Life Sci; 1993; 53(17):PL261-6. PubMed ID: 8412495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
    Harrison LM; Zadina JE; Banks WA; Kastin AJ
    Brain Res Dev Brain Res; 1993 Oct; 75(2):207-12. PubMed ID: 7903224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain peptide reverses effect of morphine on human lymphocytes.
    Strimas JH; Chi DS; Kastin AJ
    Peptides; 1987; 8(6):1165-7. PubMed ID: 2894648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the effects of Tyr-MIF-1 on morphine- and stress-induced analgesia.
    Kavaliers M; Innes DG
    Peptides; 1992; 13(6):1295-7. PubMed ID: 1362981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Gulden H; Bungart KJ
    Life Sci; 1989; 44(8):555-61. PubMed ID: 2564620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
    Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
    Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs.
    Kastin AJ; Abel DA; Ehrensing RH; Coy DH; Graf MV
    Pharmacol Biochem Behav; 1984 Nov; 21(5):767-71. PubMed ID: 6151196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiopioid properties of the TYR-MIF-1 family.
    Bocheva A; Dzambazova-Maximova E
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):673-7. PubMed ID: 15632952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.
    Banks WA; Kastin AJ
    Peptides; 1994 Jan; 15(1):23-9. PubMed ID: 7912427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies of Tyr-MIF-1 with human lymphocytes.
    Chi DS; Strimas JH; Kastin AJ
    Brain Res Bull; 1989 Dec; 23(6):549-52. PubMed ID: 2575445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.